Company Overview and News

 
Japan stocks rise on weaker yen, Nasdaq gain; US deal lifts Renesas

2018-09-11 reuters
TOKYO, Sept 11 (Reuters) - Japanese stocks had their best day in four weeks on Tuesday, with exporters lifted by the yen’s weakening against the dollar and technology shares boosted by gains for Wall Street counterparts.
ADTTF BRDCF TM RNECF TYT TOYOF TOELY KYO SUOPY 6723 7203 IDTI RNECY SUMCF 8035 TOELF ATEYY

 
Nikkei rises as yen, Nasdaq boost exporters, tech shares

2018-09-11 thehindubusinessline
Japanese stocks rose on Tuesday, with exporters lifted by the yen's weakening against the dollar and technology shares taking heart from gains in their American peers. The Nikkei share average was 0.91 per cent higher at 22,575.43.
ADTTF BRDCF TM RNECF TYT TOYOF TOELY KYO SUOPY 6723 7203 IDTI RNECY SUMCF 8035 TOELF ATEYY

 
Japan stocks gain as yen, Nasdaq boost exporters and tech shares

2018-09-11 reuters
TOKYO, Sept 11 (Reuters) - Japanese stocks rose on Tuesday, with exporters lifted by the yen’s weakening against the dollar and technology shares taking heart from gains in their American peers.
ADTTF BRDCF TM RNECF TYT TOYOF TOELY KYO SUOPY 6723 7203 IDTI RNECY SUMCF 8035 TOELF ATEYY

 
Nikkei edges up as weak yen helps mood; Continental profit warning hurts autos

2018-08-23 reuters
TOKYO, Aug 23 (Reuters) - Japan’s Nikkei edged up on Thursday after a weak yen supported overall sentiment, but a profit warning by Germany’s Continental dragged down auto stocks and tire makers.
BRDCF TM CTTAY 7203 TYT CTTAF TOYOF

 
Nikkei edges up as weak yen supports overall sentiment

2018-08-23 thehindubusinessline
Japan's Nikkei edged up on Thursday as a weak yen supported overall sentiment, but a profit warning by Germany's Continental dragged down auto stocks and tire makers. The Nikkei share average rose 0.2 per cent to 22,412.90 in midmorning trade.
BRDCF TM CTTAY 7203 TYT CTTAF TOYOF

 
Nikkei edges up on weak yen; Continental profit warning hurts autos

2018-08-23 reuters
TOKYO, Aug 23 (Reuters) - Japan’s Nikkei edged up on Thursday after a weak yen supported overall sentiment, but a profit warning by Germany’s Continental dragged down auto stocks and tire makers.
BRDCF TM CTTAY 7203 TYT CTTAF TOYOF

8
Utilities Pooling Cash for $130 Million Clean Technology Fund - Bloomberg

2018-07-11 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
DUKH BRDCF INNYY CHUEF AEP DUK CLPHF 0002 CLPHY

1
Quantitative Analysis Of The Balance Sheet: When The Rubber Hits The Road

2018-05-11 valuewalk
Welcome to the third instalment of the Road to Mastery Series, and you can read previous instalments here.
CTB BRDCF

 
What Makes Cooper Tire & Rubber Company (CTB) a Strong Sell?

2018-05-10 zacks
Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to get rid of the security before more losses hit your portfolio. One such stock that you may want to consider dropping is Cooper Tire & Rubber Company (CTB - Free Report) , which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year.
BRDCF FBC BRDCY ELLI

32
Autoliv (ALV) Q1 Earnings Lag Estimates, Revenues Surpass

2018-04-30 zacks
Autoliv, Inc. (ALV) reported adjusted earnings of $1.66 per share in first-quarter 2018, missing the Zacks Consensus Estimate of $1.81. However, the bottom line improved from the prior-year quarter’s $1.65.
BRDCF BRDCY CNA ALV BWA

 
UPDATE 2-Goodyear profit drops on weak demand, higher raw material costs

2018-04-25 reuters
(Reuters) - Goodyear Tire & Rubber Co’s (GT.O) quarterly profit more than halved on Wednesday as demand for its tires were weaker than expected and higher costs of raw materials weighed on its business.
BRDCF

38
Japan's Economy, Exports Likely to Pick Up: 5 Stocks to Buy

2018-04-19 zacks
President Donald Trump and Japan’s prime minister Shinzo Abe on Wednesday agreed to start a fresh dialogue and establish a new framework for trade and investment between the two countries. The trade talks are aimed at balancing United States’ trade deficit with Japan. Trump has been critical of Japan in recent times, describing the terms of trade between them as “not fair” because of the huge trade deficit with that country.
BRDCF BLT BHPBF WDC DSCSY RICOY BHP BRDCY 8306 MUFG BBL BHP BHPLF MBFJF MTU NJDCY NNDNF

42
Tesla (TSLA) Hikes Model 3 Production Target to 6K per Week

2018-04-18 zacks
Tesla, Inc. (TSLA - Free Report) set a target to manufacture 6,000 Model 3 cars each week by the end of June to meet its weekly target of 5,000 Model 3 units by the end of second-quarter 2018, per Bloomberg. The difference includes a margin for error of the product parts. The news was first tracked by Electrek from an email from the company’s CEO to the employees.
BRDCF ABX BRDCY MS ABX

45
Goodyear, Bridgestone to Form JV for Tire Distribution in US

2018-04-17 zacks
The Goodyear Tire & Rubber Company (GT - Free Report) announced that it is entering a 50-50 joint venture (JV) with Bridgestone Americas, Inc. (Bridgestone), which is the U.S. subsidiary of Bridgestone Corporation (BRDCY - Free Report) , to form the largest tire-distribution network in the United States. TireHub LLC, the new JV, will offer a complete range of light-truck and passenger-vehicle tires with primary importance on fulfilling the rising demand for larger rim-diameter premium tires.
BRDCF APO VLKAF BRDCY BWA MS VLKAY

10
Tiger Woods is back — the $70B golf business, not so much

2018-04-05 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
ELY BRDCF NKE PEP GOLF

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: J04578126